Corporate News 09-Apr-24
Natco Pharma receives warning letter from USFDA for its Kothur unit
Natco Pharma has received a warning letter dated 08 April 2024 from the United States Food and Drug Administration (USFDA) for its Kothur (Pharma Division) manufacturing facility. The Company does not believe that the warning letter will have an impact on disruption of supplies or existing revenues from this facility. It may cause delay/withholding of pending product approvals from this site.
Previous News
Natco Pharma standalone net profit rises 855.44% in the September 2023 quarter
( Results - Announcements 14-Nov-23 15:41 )
Natco Pharma consolidated net profit rises 549.65% in the September 2023 quarter
( Results - Announcements 14-Nov-23 17:36 )
Natco Pharma clears USFDA inspection of its Pharmacovigilance compliance
( Corporate News - 02-Nov-23 09:05 )
Natco Pharma consolidated net profit rises 241.41% in the December 2023 quarter
( Results - Announcements 15-Feb-24 16:17 )
Natco Pharma Ltd rises for third consecutive session
( Hot Pursuit - 14-May-24 13:05 )
Board of Natco Pharma recommends Interim Dividend
( Corporate News - 12-Aug-21 17:37 )
Natco Pharma consolidated net profit rises 31.18% in the June 2023 quarter
( Results - Announcements 09-Aug-23 17:06 )
Natco Pharma invests US$2 million in Cellogen Therapeutics
( Hot Pursuit - 18-Jan-24 10:49 )
Natco Pharma update on lawsuit for Glatiramer Acetate Injection
( Corporate News - 25-May-22 14:04 )
Natco Pharma launches two CTPR pesticide products
( Corporate News - 04-Oct-22 12:55 )
Natco Pharma
( Results - Analysis 11-Nov-22 16:31 )
Other Stories
Share India Securities allots 16.92 lakh equity shares on conversion of warrants
06-Jul-24 13:11
Tinna Trade raises Rs 49 cr to fund its growth plans
06-Jul-24 11:10
Integra Essentia announces merger with G G Engineering
06-Jul-24 11:05
Ugro Capital to raise Rs 75 cr via NCD issuance
06-Jul-24 10:58
Board of D.P. Abhushan approves preferential allotment of shares and warrants
06-Jul-24 10:50
Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
06-Jul-24 10:49
High Energy Batteries (India) to discuss results
06-Jul-24 10:29
Havells India schedules board meeting
06-Jul-24 10:29
Axis Bank announces board meeting date
06-Jul-24 10:29
Mastek to conduct board meeting
06-Jul-24 10:29
Back
Top
